Startups at risk: What every founder must know about today’s VC deals 

The ground is shifting beneath the feet of startup founders. As they navigate this changing landscape, a founder guide becomes essential. Gone are the ‘growth-at-all-costs’ days where a rising user count was enough to guarantee a generous valuation and founder-friendly terms. A new, more cautious era of venture capital is here, and it’s governed by a different set of rules. 

Whispers in the industry have grown into a clear consensus: VCs are tightening their grip. They are prioritizing defensible intellectual property over fleeting growth metrics and negotiating for deal terms that offer far greater downside protection for themselves. For founders who aren’t paying attention, this shift can be devastating, leading to diluted ownership, loss of control, and disappointing exits. 

This isn’t a conspiracy; it’s a market correction. But understanding this new landscape is the first step to navigating it successfully. Here’s what has changed and how you can protect your company. 

Also read: The medtech founder’s playbook: 9 rules for building a resilient business

The new reality: Investor-friendly is the new normal 

The most significant change is in the term sheet itself. While founders used to hold more leverage, the pendulum has swung back toward investors, who are now embedding protective clauses into deals with increasing frequency. 

The most critical of these is the liquidation preference. Think of it as an investor’s safety net. It dictates that in the event of a sale or liquidation, investors get their money back first, before founders, employees, and other common stockholders see a dime. 

While a standard ‘1x non-participating’ preference has long been the norm, the data shows a clear trend toward more aggressive structures. According to a 2024 report from the law firm Torys, investors are increasingly negotiating for greater downside protection, including senior liquidation preferences that put them first in line ahead of other investors. Furthermore, data from equity management platform Carta shows that tougher liquidation preference terms are at a decade-long high. Some deals even include ‘multiple’ liquidation preferences, where an investor is guaranteed two or three times their initial investment back before anyone else gets paid. 

This trend is coupled with a laser focus on defensible technology. The massive flow of capital into Artificial Intelligence is the clearest signal of this priority. VCs are funding businesses with a deep, proprietary ‘moat’—unique algorithms, exclusive data sets, and, most importantly, patents. If your pitch is heavy on traction but light on a defensible, proprietary edge, you will find it much harder to attract top-tier investment. 

Also read: EU must act on health security: MEP Adam Jarubas speaks with MedTech World

Your playbook for protection 

Navigating this tougher environment requires diligence, strategy, and a refusal to be naive. Here are the essential rules of engagement for founders today. 

1. Become a term sheet scholar 

You cannot afford to be ignorant about the terms of the deal. Before you even think about signing, you must understand the mechanics of your term sheet, especially the liquidation preference. Learn the critical difference between: 

• Non-Participating Preferred: The investor chooses to either take their money back (their preference) OR convert to common stock and share in the proceeds alongside you. This is the more founder-friendly standard. 
• Participating Preferred: The investor gets their money back AND then shares in the remaining proceeds. This ‘double-dipping’ can severely reduce the payout for everyone else. 

Your action plan: Before signing any term sheet, run a waterfall analysis. Build a simple spreadsheet that models how proceeds will be distributed to every single shareholder under different exit scenarios (e.g., a $10M sale, a $50M sale, a $500M sale). This makes the abstract legal language painfully concrete and shows you exactly how much you and your team stand to gain—or lose. 

Also read: The 7 hidden factors that decide whether your medtech startup will scale or stall

2. Protect your crown jewels before you pitch 

If your business is built on a novel technology or process, the time to protect it is before you start your fundraising roadshow. The single best way to protect your secret is not a Non-Disclosure Agreement (NDA), but a patent. 

Your action plan: File a provisional patent application. This is a relatively low-cost step that gives you ‘patent pending’ status for one year. It establishes a priority date for your invention and provides a powerful layer of protection while you talk to investors. Don’t bother asking VCs to sign an NDA; most will refuse, and it signals that you’re an amateur. Your patent filing is your shield. 

3. Control the flow of information 

In an interconnected industry, information travels fast. You must be strategic about what you share and when. Don’t reveal your most sensitive technical secrets or customer data in the first meeting. 

Your action plan: Use a tiered approach to disclosure. 

• Tier 1 (Initial Pitch): A teaser deck that outlines the problem, your solution, the market size, and your team. 
• Tier 2 (Follow-Up): For interested VCs, provide a more detailed deck with unit economics, growth strategy, and financial projections. 
• Tier 3 (Due Diligence): Only grant access to your full data room—containing technical documentation, key contracts, and other secrets—to firms that have issued a term sheet and are in the final stages of diligence. 

4. Lawyer up (the right way) 

This is not the place to cut corners. A generalist lawyer who helps with real estate closings cannot navigate the nuances of a venture financing deal. You need an experienced attorney from a firm that specializes in representing high-growth startups. They know the market standards, can spot predatory terms from a mile away, and will be your most valuable negotiating partner. View this as a critical investment in your company’s future, not an expense. 

To bone-up on the terms, pick up a copy of “Secrets of Sand Hill Road” by Scott Kupor.  This is a timeless classic that details the terms and how to navigate the terms of an investment opportunity.  

The venture landscape is challenging, but it is not impassable. By arming yourself with knowledge, protecting your intellectual property, and approaching fundraising with a clear-eyed strategy, you can secure the capital you need to build a great company without giving away the future of it.

About the Author: Bob Bouthillier is an accomplished team leader who turns complexity into actionable results. Bob has had roles from Product Manager to CEO and has led teams of up to 200 people to deliver 66 medical products to market. Bob distills the fast-changing world of AI into practical roadmaps for executives and teams.

MedTech Malta 2025

Join us at MedTech Malta 2025, taking place from 12 to 14 November, for three days of high-impact networking, thought-provoking discussions, and cutting-edge innovation at the forefront of global medical technology. Whether you’re a startup seeking investment, an executive driving digital health solutions, or a policymaker influencing the future of MedTech, this is where meaningful connections and critical conversations unfold. Don’t miss your chance to be part of it — register now and secure your place at the heart of MedTech. For more information, contact us at [email protected].